- Genmab
Infobox Company
company_name = Genmab A/S
company_
company_type = Public (OMX|CSE11143|GEN)
foundation = 1999
location =Copenhagen ,Denmark
key_people = Lisa Drakeman (President and CEO), Michael Widmer (Chairman of the board)
industry =Biotechnology
products = Pharmaceuticals, antibodies
revenue = DKK 529.5 million (2007)cite web |url=http://www.genmab.com/upload/10_2007_annual_report_310308_uk_web.pdf |title=Annual Report 2007 |publisher=Genmab A/S |accessdate=2008-05-07 |date=31 March ,2008 ]
net_income = loss (DKK 383.4 million) (2007)
num_employees= 291 (2007)
intl = yes
homepage = [http://www.genmab.com/ www.genmab.com]Genmab A/S (OMX|CSE11143|GEN) is a Danish
pharmaceutical company , founded in February 1999 and based inCopenhagen . Internationally, it operates through the subsidiaries Genmab BV in Utrecht,The Netherlands , Genmab Ltd in Stevenage,United Kingdom Genmab, Inc inPrinceton, New Jersey , USA, and is publicly traded on theOMX Nordic Exchange and theOMX Copenhagen 20 . [ [http://www.genmab.com/CompanyInformation/CompanyProfile.aspx Company Profile from the Genmab website] ] Genmab, Inc recently expanded with an antibody manufacturing facility in Brooklyn Park, Minnesota, USA.Research Pipeline
Status of major offerings in Genmab's research pipeline, as of late 2007. [ [http://www.genmab.com/ScienceAndResearch/ProductsinDevelopment.aspx Genmab.com / Products in Development ] ]
References
External links
* [http://www.genmab.com Official website]
Wikimedia Foundation. 2010.